ENDOVASCULAR TREATMENT OF A SYMPTOMATIC THORACIC AORTA THROMBI
Portuguese Journal of Cardiac Thoracic and Vascular Surgery · 17.04.2021
DOI: 10.48729/pjctvs.39 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portuguese Journal of Cardiac Thoracic and Vascular Surgery, erschienen am 17.04.2021. Verfasst von Pinto Sousa und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aortic mural thrombus is a rare condition with 0.45% incidence in the general population, being the thoracic aorta the most affected portion. In the absence of an atherosclerotic wall lesion, other specific conditions should be studied and excluded. The authors describe two clinical cases of a 64 years old male and a 48 years old female that despite a non- -atherosclerotic diseased aorta, had a thoracic mural thrombus which presented clinically with mesenteric and lower limb microembolization, respectively. Once presented with peripheral embolization, the aim should be to exclude the embolic source and prevent end organ malfunction. TEVAR has been developed as a therapeutic solution to exclude the embolic source, with a high rate of technical success and few comorbidities associated. Long term anti-coagulation is debatable but may prevent further embolization events.
Schlagwörter
Zitieren
APA
Sousa, P., Pedro, & Pinto, P. S. (2021). ENDOVASCULAR TREATMENT OF A SYMPTOMATIC THORACIC AORTA THROMBI. Portuguese Journal of Cardiac Thoracic and Vascular Surgery. https://doi.org/10.48729/pjctvs.39
Vancouver
Sousa P, Pedro, Pinto PS. ENDOVASCULAR TREATMENT OF A SYMPTOMATIC THORACIC AORTA THROMBI. Portuguese Journal of Cardiac Thoracic and Vascular Surgery. 2021. doi:10.48729/pjctvs.39
BibTeX
@article{Sousa2021,
author = {Sousa, Pinto and Pedro and Pinto, Pedro Sá},
title = {ENDOVASCULAR TREATMENT OF A SYMPTOMATIC THORACIC AORTA THROMBI},
journal = {Portuguese Journal of Cardiac Thoracic and Vascular Surgery},
year = {2021},
doi = {10.48729/pjctvs.39}
}
EUVIMED